Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Blood|February 25, 2005
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potentialDaniel Re, Roman K Thomas, Karolin Behringer, et al.
Idrugs : the Investigational Drugs Journal|June 6, 2003
Pixantrone (Novuspharma)Peter Borchmann, Marcel Reiser
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose ChemotherapyPaul J Bröckelmann, Horst Müller, Teresa Guhl, et al.
Hematology. American Society of Hematology. Education Program|January 18, 2011
The past: what we have learned in the last decadePeter Borchmann, Andreas Engert
Expert Opinion on Investigational Drugs|July 30, 2005
The role of pixantrone in the treatment of non-Hodgkin's lymphomaPeter Borchmann, Roland Schnell
Current Opinion in Molecular Therapeutics|April 14, 2006
SGN-30 (Seattle genetics)Roland Schnell, Peter Borchmann
Pageof 25